Published in Philos Trans R Soc Lond B Biol Sci on February 25, 1980
Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A (1982) 2.86
Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins. J Virol (1984) 1.28
Influenza C virus RNA 7 codes for a nonstructural protein. J Virol (1985) 0.87
Changing virulence of influenza A viruses. Trans Am Clin Climatol Assoc (1982) 0.75
Cloned poliovirus complementary DNA is infectious in mammalian cells. Science (1981) 12.50
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
Amplification, expression, and packaging of foreign gene by influenza virus. Cell (1989) 11.21
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80
Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A (1990) 7.68
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol (2000) 6.22
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Promoter analysis of influenza virus RNA polymerase. J Virol (1989) 5.66
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol (2000) 5.44
Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature (1978) 5.43
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene (1980) 5.08
The genes of influenza virus. Cell (1977) 5.05
A combined PET/CT scanner for clinical oncology. J Nucl Med (2000) 4.99
Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol (1988) 4.97
Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A (2001) 4.93
Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol (1986) 4.91
Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci U S A (1991) 4.78
Differences in RNA patterns of influenza A viruses. J Virol (1976) 4.68
Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science (1986) 4.64
Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells. J Virol (1977) 4.52
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol (1996) 4.43
Determination of influenza virus proteins required for genome replication. J Virol (1990) 4.36
High-efficiency formation of influenza virus transfectants. J Virol (1991) 4.34
A plasmid-based reverse genetics system for influenza A virus. J Virol (1996) 4.33
Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc Natl Acad Sci U S A (1987) 4.31
Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol (1986) 4.15
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology (1988) 4.03
The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J (1998) 3.98
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A (2000) 3.95
A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol (1999) 3.92
The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J Virol (1991) 3.85
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 3.77
Babies sleeping with parents: case-control study of factors influencing the risk of the sudden infant death syndrome. CESDI SUDI research group. BMJ (1999) 3.76
Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell (1990) 3.70
Improving the repeat prescribing process in a busy general practice. A study using continuous quality improvement methodology. Qual Health Care (1999) 3.61
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol (1976) 3.61
Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology (1987) 3.53
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology (2001) 3.52
What do we know about how to do audit and feedback? Pitfalls in applying evidence from a systematic review. BMC Health Serv Res (2005) 3.51
Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J Virol (1994) 3.49
The Uterine Mucosa in Menstruation and Pregnancy; the Action of the Chorionic Cells and the Function of the Decidua: Structure of the Uterine Mucosa and the Cause of the Opening-up of the Vessels during Menstruation. Proc R Soc Med (1911) 3.46
Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue. Histopathology (2000) 3.36
Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc Natl Acad Sci U S A (1976) 3.19
Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA. J Mol Biol (1981) 3.18
Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains. Proc Natl Acad Sci U S A (1979) 3.13
The AEtiology of Eclampsia and Albuminuria and their Relation to Accidental Haemorrhage: (An Anatomical and Experimental Investigation.). Proc R Soc Med (1914) 3.13
Morphology of sporadic colorectal cancer with DNA replication errors. Gut (1998) 3.11
Sequence diversity of small, round-structured viruses in the Norwalk virus group. J Virol (1994) 3.11
RNAs of influenza A, B, and C viruses. J Virol (1976) 3.10
Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol (2001) 3.07
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics (2001) 3.02
Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest (1981) 2.97
Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5'-noncoding region of the viral RNA. Virology (1986) 2.95
Incidence and consequences of falls due to stroke: a systematic inquiry. BMJ (1995) 2.94
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J Virol (1999) 2.90
The role of interferon in influenza virus tissue tropism. J Virol (1998) 2.88
Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A (1982) 2.86
DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol (1999) 2.78
Neutralization of poliovirus by cell receptors expressed in insect cells. J Virol (1990) 2.77
Variation of influenza A, B, and C viruses. Science (1982) 2.75
NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology (1995) 2.74
Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed (1999) 2.73
Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein. J Virol (1976) 2.73
Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol (1975) 2.72
Construction and characterization of poliovirus subgenomic replicons. J Virol (1988) 2.69
Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. Br J Clin Pharmacol (1978) 2.68
Recombinant Newcastle disease virus as a vaccine vector. J Virol (2001) 2.67
An influenza virus containing nine different RNA segments. Virology (1991) 2.66
A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med (1997) 2.66
Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci U S A (1989) 2.65
Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci U S A (2000) 2.64
An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice. Proc Natl Acad Sci U S A (1991) 2.55
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J Virol (1997) 2.51
Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol (1989) 2.46
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A (1993) 2.44
Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol (1993) 2.40
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol (1987) 2.36
Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol (1988) 2.34
Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol (2001) 2.33
Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology (1983) 2.32
Expression of a foreign protein by influenza A virus. J Virol (1994) 2.28
Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci (2001) 2.28
Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res (1980) 2.25